HomeLINCOLN • NSE
add
Lincoln Pharmaceuticals Ltd
Previous close
₹661.60
Day range
₹655.15 - ₹672.00
Year range
₹391.95 - ₹755.15
Market cap
13.25B INR
Avg Volume
66.09K
P/E ratio
14.19
Dividend yield
-
Primary exchange
NSE
Market news
.INX
1.02%
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.42B | 26.71% |
Operating expense | 532.19M | 18.59% |
Net income | 185.97M | 48.05% |
Net profit margin | 13.05 | 16.83% |
Earnings per share | — | — |
EBITDA | 183.53M | 8.00% |
Effective tax rate | 16.29% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.53B | 34.20% |
Total assets | 7.00B | 19.21% |
Total liabilities | 1.07B | 26.50% |
Total equity | 5.93B | — |
Shares outstanding | 20.04M | — |
Price to book | 2.24 | — |
Return on assets | — | — |
Return on capital | 6.88% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 185.97M | 48.05% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Website
Employees
1,645